SCHEMBL7095517

SCHEMBL7095517

CC1Oc2ccc(C(Cc3cccc([N+](=O)[O-])c3)NC(=O)OC(C)(C)C)cc2NC1=S

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SIRT2 Q8IXJ6 1/20 0.38
NR3C2 P08235 1/20 0.38
RAB9A P51151 4/20 0.36
MAPT P10636 3/20 0.36
SMN1; SMN2 Q16637 2/20 0.36
ALOX5 P09917 1/20 0.36
NPC1 O15118 1/20 0.36
ITGA4 P13612 1/20 0.34
ITGB7 P26010 1/20 0.34
HTT P42858 4/20 0.34
L3MBTL1 Q9Y468 1/20 0.34
ALDH1A1 P00352 5/20 0.33
HPGD P15428 3/20 0.33
NPSR1 Q6W5P4 3/20 0.33
LMNA P02545 2/20 0.33
PKM P14618 2/20 0.33
KMT2A Q03164 2/20 0.33
JAK2 O60674 2/20 0.33
TP53 P04637 2/20 0.33
HSD17B10 Q99714 2/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7713283 0.91 PARP1 (0.40) SIRT2NR3C2RAB9AMAPTSMN1; SMN2
SCHEMBL7710783 0.91 PPARG (0.39) RAB9AMAPTSMN1; SMN2NPC1ITGA4
SCHEMBL7711070 0.89 CACNA1B (0.40) RAB9AMAPTSMN1; SMN2HTTL3MBTL1
SCHEMBL7704943 0.88 ALDH1A1 (0.43) RAB9AMAPTSMN1; SMN2HTTALDH1A1
SCHEMBL7708252 0.87 CTSL (0.45) SIRT2MAPTSMN1; SMN2HTTALDH1A1
SCHEMBL7090483 0.87 CTSS (0.45) RAB9AMAPTSMN1; SMN2HTTALDH1A1
SCHEMBL7091516 0.86 SCN9A (0.39) HTTALDH1A1HPGDNPSR1JAK2
SCHEMBL7094044 0.84 SMN1; SMN2 (0.40) RAB9AMAPTSMN1; SMN2HTTALDH1A1
SCHEMBL7095640 0.83 ALDH1A1 (0.37) RAB9AMAPTSMN1; SMN2HTTALDH1A1
SCHEMBL7091267 0.83 HSD17B10 (0.33) RAB9AMAPTSMN1; SMN2HTTALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1015437-B1 BENZOXAZINE AND BENZOTHIAZINE DERIVATIVES AND THEIR USE IN PHARMACEUTICALS SCHERING AG (DE) 2003-12-03 EP disclosed
US-6365736-B1 TREATMENT OF NERVOUS SYSTEM DISORDERS, CARDIOVASCULAR DISORDERS AND FOR ACTIVITY AS NO-SYNTHASES (NOS) INHIBITORS. SCHERING AKTIENGESELLSCHAFT (DE) 2002-04-02 US disclosed